Outset Medical Return on Tangible Equity 2019-2024 | OM

Current and historical return on tangible equity values for Outset Medical (OM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Outset Medical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.14B $0.05B -169.37%
2024-06-30 $-0.16B $0.07B -145.54%
2024-03-31 $-0.17B $0.09B -122.69%
2023-12-31 $-0.17B $0.12B -102.67%
2023-09-30 $-0.18B $0.15B -87.83%
2023-06-30 $-0.17B $0.18B -73.59%
2023-03-31 $-0.17B $0.22B -64.70%
2022-12-31 $-0.16B $0.25B -55.25%
2022-09-30 $-0.16B $0.28B -49.85%
2022-06-30 $-0.15B $0.31B -42.25%
2022-03-31 $-0.14B $0.35B -35.38%
2021-12-31 $-0.13B $0.37B -34.43%
2021-09-30 $-0.10B $0.41B -28.17%
2021-06-30 $-0.12B $0.43B -32.65%
2021-03-31 $-0.11B $0.31B -45.66%
2020-12-31 $-0.08B $0.33B -46.85%
2020-06-30 $-0.04B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.045B $0.130B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Inspire Medical Systems (INSP) United States $5.716B 178.27
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Standard BioTools (LAB) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
111 (YI) China $0.056B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00